P-042: Phase 1 dose-escalation study of sotatercept in combination with lenalidomide and dexamethasone or pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

Autor:	Andrew Yee, Jacob Laubach, Ajay Nooka, Elizabeth O’Donnell, Cynthia Harrington, Emerentia Agyemang, Jill Burke, Marilyn Gammon, Kathleen Lively, Lisette Packer, James Bishop, Zachary Bernstein, Rebecca Lyons, Alexandra Wright, Cailin McVey, Paul Richardson, Noopur Raje
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S58-S59
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)00372-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0d314e0cf39f2df24985e11d44700d37 https://doi.org/10.1016/s2152-2650(22)00372-x Zobrazit plný text záznamu Full Text from ScienceDirect